Iloprost Pharmamentum

Iloprost, the active ingredient in Iloprost Pharmamentum, is a prostacyclin analog presented as an intravenous solution for intravenous use. It is employed to treat pulmonary arterial hypertension and digital ulcers associated with systemic sclerosis, providing vasodilation and inhibition of platelet aggregation.

GNH USA supplies Iloprost Pharmamentum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, adhering to stringent quality standards and offering reliable global distribution.

Iloprost acts on the prostacyclin pathway to provide vasodilatory therapy for pulmonary vascular disease and related conditions.

- Pulmonary arterial hypertension: improves exercise capacity and reduces pulmonary vascular resistance. - Digital ulcers associated with systemic sclerosis: promotes ulcer healing and reduces pain. - Pulmonary hypertension (including secondary forms): provides vasodilation and improves hemodynamic parameters.

Iloprost may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: transient throbbing pain during infusion. - Flushing: warm sensation and reddening of skin. - Nausea: mild gastrointestinal upset. - Infusion site pain: discomfort at the injection site.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring intervention. - Pulmonary edema: fluid accumulation in lungs. - Bleeding complications: increased risk of hemorrhage, especially with anticoagulants.

Prior to initiating Iloprost therapy, several precautions should be considered to ensure safe use.

- Renal impairment: monitor renal function and adjust infusion rate as needed. - Hepatic impairment: use with caution and observe liver enzymes. - Bleeding risk: avoid concomitant anticoagulants unless clinically required. - Hypotension: monitor blood pressure during and after infusion. - Pregnancy: prescribe only if potential benefits justify potential risks to the fetus. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iloprost can interact with other medications, influencing its safety and efficacy.

Major Interactions (Avoid): - Concomitant potent vasodilators (e.g., nitroglycerin): risk of severe hypotension. - Epoprostenol: additive vasodilatory effect may cause profound hypotension. - Anticoagulants: increased bleeding risk.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance hypotensive response. - Beta‑blockers: may mask tachycardia associated with hypotension. - Diuretics: can affect fluid balance and blood pressure during infusion.